Original Research

Obstructive sleep apnea: A better Dx model for primary care

Author and Disclosure Information

This study identified a method that provides a truer assessment of disease probability than has been achieved with history and physical exam evaluation.


 

References

ABSTRACT

Purpose To derive a predictive model for obstructive sleep apnea (OSA) in primary care practice, using home-based overnight oximetry results to refine posttest probability (PTP) of disease after initial risk stratification with the Sleep Apnea Clinical Score (SACS).

Methods We performed secondary analyses on data from a SACS validation cohort, to compare the diagnostic accuracy of 3 overnight oximetry measurements (oxygen desaturation index [ODI], mean saturation, and minimum saturation) in predicting OSA. Receiver operator characteristics (ROC) were computed for each measurement independently and sequentially after risk stratifying with SACS. We examined the implications of oximetry results for OSA PTP for participants categorized as intermediate risk (SACS 6-14; 66/191 participants [35%]; OSA probability 41%). We calculated positive likelihood ratios (LR) for multiple ODI results and determined which ones allowed recalibration to high- or low-risk PTP.

Results Among the 3 oximetry findings, ODI best predicted OSA (area under the curve [AUC], 0.88; 95% confidence interval [CI], 0.83-0.93). An ODI ≥8.4 (likelihood ratio [LR], 4.19; 95% CI, 2.87-6.10) created a PTP of 77%, while an ODI of 0 to <8.4 (LR, 0.19, 95% CI, 0.12-0.33) created a 14% PTP. Sequential application of SACS and ODI results yielded an AUC result of 0.90 (95% CI, 0.85-0.95).

Conclusions SACS risk stratification provides an advantage over clinical gestalt. In those at intermediate risk, ODI results provide a simple and clinically useful way to further refine diagnostic prediction. Sequential use of SACS and selectively employed overnight oximetry may limit unnecessary polysomnography. Oximetry testing should be avoided in patients deemed low or high risk by SACS, as positive results do not substantially recalibrate risk.

Obstructive sleep apnea (OSA) is a prevalent and underdiagnosed condition. The National Sleep Foundation estimates that 18 million Americans have OSA.1 Primary care practice may be the best setting in which to identify OSA, as many of our patients have conditions frequently associated with apnea (eg, hypertension, obesity, diabetes, arrhythmia, and neurologic illness). Up to a third of patients in primary care practice may be at increased risk.2,3

Clinical guidelines of the American Academy of Sleep Medicine (AASM) recommend obtaining a sleep history to evaluate for possible OSA in 3 instances: as part of a routine health maintenance examination, during evaluation of specific complaints associated with OSA (eg, snoring, apnea, daytime sleepiness), and during comprehensive evaluations for individuals with high-risk conditions (ie, obesity, congestive heart failure, refractory hypertension, diabetes, stroke history).4

Providers can't simply rely on clinical gestalt when obstructive sleep apnea is suspected.

The American College of Physicians (ACP) Clinical Practice Guideline suggests assessing individuals who have unexplained daytime sleepiness.5 The ACP considers this assessment “High-Value Care,” as “evidence shows that before diagnosis, patients with OSA have higher rates of health care use, more frequent and longer hospital stays, and higher health care costs than after diagnosis.”5

Continue to: We recently validated the diagnostic accuracy...

Pages

Recommended Reading

Opioid use predicts longer sleep latency in chronic pain patients
MDedge Family Medicine
Pregnancy registries are a valuable resource
MDedge Family Medicine
Obesity plays role in sleep-disordered breathing in pregnancy
MDedge Family Medicine
Digital CBT improves health, well-being, quality of life in randomized trial
MDedge Family Medicine
Does America have a gabapentinoid problem?
MDedge Family Medicine
Obesity: When to consider surgery
MDedge Family Medicine
Sexual assault and harassment linked to hypertension, depression, and anxiety
MDedge Family Medicine
ADVENT-HF early results: High ASV compliance, no safety concerns
MDedge Family Medicine
Pediatric OSA linked to abnormal metabolic values
MDedge Family Medicine
FDA approves Xyrem to treat children with narcolepsy
MDedge Family Medicine